Ludwigshafen, Germany

Lisa Baust

USPTO Granted Patents = 22 

 

 

Average Co-Inventor Count = 3.0

ph-index = 14

Forward Citations = 603(Granted Patents)


Company Filing History:


Years Active: 2012-2018

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: Lisa Baust: Pioneering Innovations in Biopharmaceuticals

Introduction

Lisa Baust, a prominent inventor based in Ludwigshafen, Germany, is known for her significant contributions to the field of biopharmaceuticals. With a remarkable portfolio of 22 patents, she has established herself as an influential figure in medical research and biotechnology. Her work focuses primarily on formulations that enhance the stability and efficacy of human antibodies.

Latest Patents

Among Lisa’s latest patents is a remarkable formulation for human antibodies aimed at treating TNF-alpha associated disorders. This innovative liquid aqueous pharmaceutical formulation is characterized by a high protein concentration and a pH range of between 4 and 8, which contributes to improved stability. This advancement has the potential to revolutionize treatment options for patients suffering from various inflammatory diseases.

Career Highlights

Lisa has accumulated extensive experience by working with notable companies in the biotechnology sector. She has been associated with AbbVie Biotechnology Ltd and Abbott Biotechnology Ltd, where she applied her expertise to develop cutting-edge pharmaceutical solutions. Her career showcases a consistent trajectory of innovation and commitment to enhancing therapeutic treatments.

Collaborations

Throughout her career, Lisa has collaborated with prominent colleagues, including Michael Dickes and Hans-Juergen Krause. These partnerships have played a crucial role in driving her research forward and fostering advancements in the field of biopharmaceuticals.

Conclusion

In summary, Lisa Baust stands out as a visionary inventor whose work on human antibody formulations addresses critical medical needs. Her contributions through her patents are vital to the ongoing progress in treating TNF-alpha associated disorders, and her collaborations with industry leaders underscore her impact on the biotechnology landscape. As innovation continues to evolve, Lisa Baust will undoubtedly remain a key player in the quest for breakthrough medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…